Skip to main content

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

Volume 6, Number 3, September 2006

Articles

Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy
pp. 223-237(15)
Authors: Frumento, Guido; Piazza, Tiziana; Di Carlo, Emma; Ferrini, Silvano

Favourites:
ADD

Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling
pp. 239-247(9)
Authors: Iwatsubo, Kousaku; Okumura, Satoshi; Ishikawa, Yoshihiro

Favourites:
ADD
Favourites:
ADD

Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
pp. 271-277(7)
Authors: Ranieri, Girolamo; Ruggieri, Eustachio; Falco, Gaetano; Zizzo, Nicola; Mattioli, Eliseo; Francesco Zito, Alfredo; Patruno, Rosa; Gasparini, Giampietro

Favourites:
ADD

Origin and Biological Significance of Shed-Membrane Microparticles
pp. 287-294(8)
Authors: Tesse, A.; Martinez, M. C.; Meziani, F.; Hugel, B.; Panaro, M. A.; Mitolo, V.; Freyssinet, J.-M.; Andriantsitohaina, R.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more